Ona Therapeutics

Series-B+
ona-therapeutics.com Biotech & Healthcare Barcelona, Spain Founded 2019 11-50
Total Funding $207.1M
Latest Round $86.6M Series-B+
Last Announced Oct 5, 2026
Investors 10 Backers
Decision Makers 6 Verified

About Ona Therapeutics

Ona Therapeutics develops antibody-drug conjugates (ADCs) and antibody-based therapies. It focuses on identifying novel therapeutic targets by studying the molecular characteristics of refractory cancers. The company aims to provide new treatments for patients with advanced cancer who have limited options.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B+
Global Headquarters Barcelona, Spain
Year Founded 2019
Team Size 11-50
Tracked Since Sep 29, 2026

Web & Domain Identity

Official Website ona-therapeutics.com
Domain Registered Date Mar 26, 2019

Social & Network Presence

X / Twitter Profile @OnaTherapeutics (402 followers) Created on Jul 2019
LinkedIn Corporate Not linked

Company Milestones & Timeline

6 Events
  1. Capital Raise

    Raised $86,600,000 · Series-B+

    irbbarcelona.org

  2. Capital Raise

    Raised $86,600,000 · Series-B+

    fundraisingfox.com

  3. Capital Raise

    Raised $33,924,000 · Series-A

  4. Milestone

    X account created (@OnaTherapeutics)

    402 followers

  5. Milestone

    Website domain registered

    ona-therapeutics.com

  6. Milestone

    Company founded

    Barcelona, Spain

Investors & Backers

10
Alta Life Sciences
Asabys Partners
Bpifrance
CDTI Innovación's INNVIERTE program
COFIDES
Columbus Venture Partners
Fund+
Korys
Mérieux Equity Partners
Ysios Capital

Funding History

3 Rounds
Series-B+ · Oct 5, 2026
$86,600,000 irbbarcelona.org
Series-B+ · Jun 4, 2026
Series-A · Jun 16, 2020
$33,924,000 Source

Founders & Leadership

4

Joel Mairet

Director

Work email & phone locked Unlock →

Jutta Amersdorffer

Chief Medical Officer

Work email & phone locked Unlock →

Salvador Aznar Benitah

scientific co-founder

Work email & phone locked Unlock →

Valerie Vanhooren

Co-founder and Chief Executive Officer

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts